high, as may occur among patients taking ascorbic acid, other techniques such as the addition of NaNO2 or FeC13 and Na2EDTA (7, 9, 10) would be required to prevent conversion of ascorbate to oxalate when analytical procedures require even brief alkalinization of urine samples. We have also considered our observations in relation to measurements of urinary oxalate excretion, also using the method of Hodgkinson and Williams (9), among patients with nephrolithiasis eating ad libitwn before and during the administration of potassium citrate, 60 mEq/day (11, 12). In those studies, the urinary pH averaged -6.0 before treatment and -6.7 while the subjects took potassium citrate, pH increments comparable with those observed in the present study. Despite the more alkaline urines, oxalate excretion, which averaged -350 .anoJJday, either did not change (11) or increased by only -10% (12). We have no explanation for these discrepant observations. We conclude that urines for the measurement of oxalate excretion must be collected in acid to prevent artifactual increase in urinary oxalate concentrations as a result of the in vitro nonenzymatic conversion of ascorbate to oxalate when the urinary pH exceeds 6.0. 
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AddftlonalKeyphrases: abused drugs . cutoff values
For some time we have been using EMIT DAU reagents (Syva Co., Palo Alto, CA) for cocaine metabolite with a Hitachi 705 (Boehringer Mannheim, Indianapolis, IN) automatic analyzer. Our cutoff limit for positive detection is 50 g/L, one-sixth that recommended by Syva. The confirmation rate by full-scan gas chromatography/mass spectrometry (GC/MS) has exceeded 96%. Most of the samples that were not confirmed had interfering mass spectral peaks; thus, although not truly negative, they did not meet our criteria for full-scan confirmation. The cocaine metabolite assay for the TDx (Abbott Labs., N. Chicago, IL), an automatic analyzer that makes use of the fluorescence polarization immunoassay technique, has been evaluated previously by Poklis (1 
Apparatus
We screened samples with an Abbott TDx automatic analyzer. Abbott cocaine metabolite reagents (lot no. 205 Y. = estimate of the expected signal response 18SV) were used as supplied. Before use, Abbott calibrators n number of standards (Syva lot no. 169355V) were diluted 10-fold with drug-free t = Student's t-value corresponding to n -2 degrees Syva-supplied urine (lot no. A1G) to give concentrations of of freedom and (1 -a) or (1 -/3) confidence level. 0, 30, 100, 200, 300, and 500 gfL. We calibrated the The decision limit, y, may be calculated as: analyzer according to the TDx product insert, using these diluted calibrators after adjusting the minimum span to 30 N/n from9o.TheTDxresultsthatwereprinted(inmg/L)could y=y-b+st1 times the actual concentration when controls or samples were analyzed. The negative calibrator we used was supEquation 1 is used to calculate the detection limit, xD, by plied by Abbott. For numerical results to be printed in successive approximation by varying x until y = That addition to ">T" and "<T" for samples above and below concentration of x is then equal to x. threshold concentrations, the TDx '1 print" function was set toO.
Results and DiscussIon
For GC/MS analyses we used a Model 4000 mass spectrometer (Finnigan, San Jose, CA). We injected the samTo determine a presumptive decision limit, we used the ples onto a J&W (Folsom, to TDx data (to determine These determinations were made under ideal conditions: the cutoff value for the modified calibration method in a single pooled urine was used to prepare all controls. In a analyses of urine for benzoylecgonine), we had to determine real analytical situation, variability between urine samthe decision limit, y,, above which the TDx response could ples would increase the variance observed for any given be reliably differentiated from a negative sample response. drug concentration. Thus these theoretical detection limits The detection limit is the sample concentration that will, at are the best that can be expected for the method. For a certain specified confidence level, yield a positive meapractical use, somewhat higher limits would be needed. tively. Regression analysis of these data produced the equation x = 0.00902y + 0.02603 (r2 = 0.907). Table 1 summarizes results of calculations of detection limit based on these data. The decision limit determined for these data at the 99% confidence level, 44 pg/L, would have identified 
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unduly increasing the number of negative samples identified as presumptive positives and requiring the expense of GC/MS confirmation. if the majority of cocaine users are to be detected, this decrease in detection limit is necessary. Analysis of data from samples found during three months by our laboratory to contain cocaine metabolite showed that 62% would not have been detected with a 300 ug/L cutoff and 49% would not have been detected with a i50 pg/L cutoff. Simple modification of other TDx assays might yield similar reductions in limits of detection.
We thank Mr. Guillermo C. Ford, MT(ASCP), for his assistance.
References
only two presumptive positives among the 90 known negative samples analyzed.
In addition, in analysis of 74 patients' urines previously found to contain cocaine metabolite in concentrations ranging from 50 to iOO pg/L, 96% gave TDx values exceeding the 44 pgfL detection limit.
We conclude that the Abbott TDx detection limit for benzoylecgonine may be lowered by trivially modifying the procedure from the 300 pg/L cutoff suggested by Abbott Laboratories.
Even considering the variability of urine samples, this modification may be safely enacted without
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